Streptococcus mitis as a New Emerging Pathogen in Pediatric Age: Case Report and Systematic Review

Antibiotics (Basel). 2023 Jul 23;12(7):1222. doi: 10.3390/antibiotics12071222.

Abstract

Streptococcus mitis, a normal inhabitant of the oral cavity, is a member of Viridans Group Streptococci (VGS). Generally recognized as a causative agent of invasive diseases in immunocompromised patients, S. mitis is considered to have low pathogenic potential in immunocompetent individuals. We present a rare case of sinusitis complicated by meningitis and cerebral sino-venous thrombosis (CSVT) caused by S. mitis in a previously healthy 12-year-old boy with poor oral health status. With the aim of understanding the real pathogenic role of this microorganism, an extensive review of the literature about invasive diseases due to S. mitis in pediatric patients was performed. Our data define the critical role of this microorganism in invasive infections, especially in immunocompetent children and in the presence of apparently harmful conditions such as sinusitis and caries. Attention should be paid to the choice of therapy because of VGS's emerging antimicrobial resistance patterns.

Keywords: S. mitis; VGS; invasive disease; pediatric.

Publication types

  • Review

Grants and funding

The publication costs of this article were covered by the Fund for VQR Improvement assigned to the Department of Health Promotion, Mother and Child Care, Internal Medicine, and Medical Specialties of the University of Palermo.